3.0.0 694 2025-12-05T22:48:17Z 2025-12-05T22:48:17Z Senate S S 2025-02-24 119 https://www.congress.gov/bill/119th-congress/senate-bill/694 ssfi00 Finance Committee Senate Standing Referred To 2025-02-24T22:20:07Z 119 1476 HR 2025-02-21 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Identical bill CRS 2025-02-24 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2025-02-24 Introduced in Senate IntroReferral 10000 9 Library of Congress T000476 Sen. Tillis, Thomas [R-NC] Thomas Tillis R NC Roland N K000377 Sen. Kelly, Mark [D-AZ] Mark Kelly D AZ 2025-02-24 True B001305 Sen. Budd, Ted [R-NC] Ted Budd R NC 2025-04-08 False P000145 Sen. Padilla, Alex [D-CA] Alex Padilla D CA 2025-04-08 False Health Blood and blood diseases 2025-07-17T17:25:05Z Drug therapy 2025-07-17T17:25:05Z Health care costs and insurance 2025-07-17T17:25:05Z Manufacturing 2025-07-17T17:25:05Z Medicare 2025-07-17T17:25:05Z Prescription drugs 2025-07-17T17:25:05Z Health 2025-03-21T14:06:53Z

00 2025-02-24 Introduced in Senate 2025-08-18T19:08:45Z <p><strong>Preserving Life-saving Access to Specialty Medicines in America Act or the PLASMA Act</strong></p><p>This bill phases-in certain price adjustments for plasma-derived products under the Medicare prescription drug benefit's Manufacturer Discount Program.</p><p>Current law requires manufacturers of covered drugs under the Medicare prescription drug benefit to provide a 10% discount for covered drugs during the initial coverage phase (i.e., before a beneficiary reaches the out-of-pocket spending threshold) and a 20% discount during the catastrophic coverage phase (i.e., after a beneficiary reaches the out-of-pocket spending threshold).&nbsp;</p><p>The bill phases-in discounts for plasma-derived products over several years, starting with a 1% discount in 2026 for both the initial and catastrophic coverage phases, and ending with a 10% discount beginning in 2030 for the initial coverage phase and a 20% discount beginning in 2032 for the catastrophic coverage phase.</p>

Display Title 45 2025-04-09T11:03:17Z Short Title(s) as Introduced 101 2025-03-20T03:23:18Z Introduced in Senate IS Short Title(s) as Introduced 101 2025-03-20T03:23:18Z Introduced in Senate IS Official Title as Introduced 6 2025-03-20T03:18:33Z Introduced in Senate IS Introduced in Senate 2025-02-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s694is/xml/BILLS-119s694is.xml 2025-02-24 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.